# High Dose Candesartan Versus Quinapril for Restenosis Prophylaxis After Stent Angioplasty

> **NCT00154050** · NA · COMPLETED · sponsor: **Technische Universität Dresden** · enrollment: 22 (—)

## Conditions studied

- Arterial Occlusive Diseases

## Interventions

- **DRUG:** candesartan (drug) or quinapril (drug)

## Key facts

- **NCT ID:** NCT00154050
- **Lead sponsor:** Technische Universität Dresden
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 22 (—)
- **Last updated:** 2006-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00154050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00154050, "High Dose Candesartan Versus Quinapril for Restenosis Prophylaxis After Stent Angioplasty". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00154050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*